Latest News
Semaglutide associated with fewer cognitive problems in people with mental illness
24 August 2026
Semaglutide, widely used to treat diabetes and obesity, was associated with fewer cognitive signs and symptoms in people with psychiatric disorders, according to a new study led by researchers at the University of Oxford.
New audit system maps how mental-health risks emerge in AI chatbot conversations
7 August 2026
Scientists have developed a framework for stress-testing how AI chatbots respond to vulnerable users, helping researchers identify weaknesses and test ways of making mental-health interactions safer.
AI could help identify patients at risk of psychosis more quickly
23 July 2026
AI has been shown to be effective in identifying and analysing symptoms from psychiatric interviews, which could help speed up assessments and access to care for those who need it most, according to a new study.
Talks, discussions, events
NIHR Oxford Health BRC
© NIHR Oxford Health BRC
Find out more about the Oxford Health Biomedical Research Centre (BRC) based in the Department of Psychiatry.

